New Progress in Diagnosis and Management of Asthma

Dear Colleagues,

Asthma is the most common non-communicable disease worldwide, and the morbidity rate increases every year. As a heterogeneous disease, asthma is often underdiagnosed or -treated. The disease complexity explains its inclusion in the list of incurable diseases, so only phenotypic diagnosis and individualized treatments can control the course and severity of the disease and improve the patients’ quality of life.

This Special Issue aims to address the latest findings in the field of diagnostics and management of asthma. The original works may include novel molecular and epigenetic biomarkers, asthma phenotyping, as well as the latest advances in management of severe asthma through the precision medicine, selectively targeting the eosinophils, neutrophils, T2 and non-T2 cytokines, and alarmins.

In this Special Issue, original research articles and reviews are welcome.

The topics include, but are not limited to:

• Pathophysiology in asthma;
• Genomics, metabolomics, and epigenetics in asthma;
• Biomarkers in asthma;
• Airway remodeling in asthma;
• Phenotypes and endotypes in asthma;
• Advances in therapy in asthma;
• Biologics in asthma.

I look forward to receiving your contributions.

Prof. Dr. Kęstutis Malakauskas
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• asthma
• biomarkers
• phenotyping
• management
• biological